Lifecore Biomedical, Inc. De (LFCR) EBT (2010 - 2025)

Lifecore Biomedical's EBT history runs 16 years deep, the most recent figure standing at -$1.1 million for Q2 2025.

• In Q2 2025, EBT rose 84.4% year-over-year to -$1.1 million; the TTM figure through May 2025 stood at -$38.7 million (down 506.5% YoY), while the FY2025 annual figure was -$38.7 million, down 506.5% from the prior year.
• EBT was -$1.1 million for Q2 2025 at Lifecore Biomedical, up from -$14.8 million in the prior quarter.
• In the past five years, EBT ranged from a high of $15.0 million in Q1 2024 to a low of -$36.8 million in Q2 2023.
• Historically, EBT has averaged -$7.6 million across 5 years, with a median of -$7.3 million in 2022.
• The sharpest annual moves came in 2021 and 2023: EBT sank 8527.43% in 2021, then surged 254.15% in 2023.
• A 5-year view of EBT shows it stood at $1.3 million in 2021, then slumped by 823.03% to -$9.2 million in 2022, then soared by 254.15% to $14.2 million in 2023, then plunged by 146.05% to -$6.5 million in 2024, then surged by 82.94% to -$1.1 million in 2025.
• The last three EBT figures came in at -$1.1 million (Q2 2025), -$14.8 million (Q1 2025), and -$6.5 million (Q4 2024), per Business Quant data.